Terms: = Cervical cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Treatment
3 results:
1. G protein coupled receptor kinase 5 modifies the nucleolar stress response activated by actinomycin D.
Sok V; Jacinto AZ; Peng N; Eldemerdash M; Le L; Tran PD; Feng LF; Patel JR; Gi M; Ammon JC; So CH
Biochem Cell Biol; 2021 Aug; 99(4):508-518. PubMed ID: 33507833
[TBL] [Abstract] [Full Text] [Related]
2. Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer.
Sarduy MR; García I; Coca MA; Perera A; Torres LA; Valenzuela CM; Baladrón I; Solares M; Reyes V; Hernández I; Perera Y; Martínez YM; Molina L; González YM; Ancízar JA; Prats A; González L; Casacó CA; Acevedo BE; López-Saura PA; Alonso DF; Gómez R; Perea-Rodríguez SE;
Br J Cancer; 2015 May; 112(10):1636-43. PubMed ID: 25880012
[TBL] [Abstract] [Full Text] [Related]
3. CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research.
Perea SE; Baladron I; Garcia Y; Perera Y; Lopez A; Soriano JL; Batista N; Palau A; Hernández I; Farina H; Garcia I; Gonzalez L; Gil J; Rodriguez A; Solares M; Santana A; Cruz M; Lopez M; Valenzuela C; Reyes O; López-Saura PA; González CA; Diaz A; Castellanos L; Sanchez A; Betancourt L; Besada V; González LJ; Garay H; Gómez R; Gómez DE; Alonso DF; Perrin P; Renualt JY; Sigman H; Herrera L; Acevedo B
Mol Cell Biochem; 2011 Oct; 356(1-2):45-50. PubMed ID: 21735096
[TBL] [Abstract] [Full Text] [Related]
